BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12639654)

  • 1. Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy.
    Froehner M; Koch R; Litz R; Oehlschlaeger S; Noack B; Manseck A; Albrecht DM; Wirth MP
    Urology; 2003 Mar; 61(3):596-600. PubMed ID: 12639654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy.
    Froehner M; Koch R; Litz R; Heller A; Oehlschlaeger S; Wirth MP
    Urology; 2003 Oct; 62(4):698-701. PubMed ID: 14550446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy.
    Froehner M; Koch R; Heberling U; Novotny V; Hübler M; Wirth MP
    Urol Oncol; 2017 Jan; 35(1):32.e17-32.e23. PubMed ID: 27519277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older.
    Froehner M; Koch R; Hübler M; Zastrow S; Wirth MP
    Eur Urol; 2017 May; 71(5):710-713. PubMed ID: 27793476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Twelker L; Hakenberg OW; Wirth MP
    Urology; 2008 Dec; 72(6):1252-7. PubMed ID: 18723211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.
    Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
    Urology; 2006 Sep; 68(3):583-6. PubMed ID: 16979740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined index to classify prognostic comorbidity in candidates for radical prostatectomy.
    Froehner M; Kellner AE; Koch R; Baretton GB; Hakenberg OW; Wirth MP
    BMC Urol; 2014 Mar; 14():28. PubMed ID: 24678762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Oehlschlaeger S; Hakenberg OW; Wirth MP
    Eur Urol; 2005 Feb; 47(2):190-5; discussion 195. PubMed ID: 15661413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Haase M; Klenk U; Oehlschlaeger S; Baretton GB; Wirth MP
    Scand J Urol Nephrol; 2005; 39(6):449-54. PubMed ID: 16303719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.
    Froehner M; Koch R; Litz RJ; Hakenberg OW; Oehlschlaeger S; Wirth MP
    J Urol; 2008 May; 179(5):1823-9; discussion 1829. PubMed ID: 18355873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which conditions contributing to the Charlson score predict survival after radical prostatectomy?
    Froehner M; Koch R; Litz R; Oehlschlaeger S; Wirth MP
    J Urol; 2004 Feb; 171(2 Pt 1):697-9. PubMed ID: 14713789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which comorbidity classification best fits elderly candidates for radical prostatectomy?
    Froehner M; Hentschel C; Koch R; Litz RJ; Hakenberg OW; Wirth MP
    Urol Oncol; 2013 May; 31(4):461-7. PubMed ID: 21498089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of comorbidity, age and perioperative complications in patients undergoing radical prostatectomy.
    Froehner M; Litz R; Manseck A; Hakenberg OW; Leike S; Albrecht DM; Wirth MP
    Urol Int; 2001; 67(4):283-8. PubMed ID: 11741129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy.
    Tollefson MK; Boorjian SA; Gettman MT; Rangel LJ; Bergstralh EJ; Karnes RJ
    Urol Oncol; 2013 Nov; 31(8):1483-8. PubMed ID: 22578510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: a proposal of a novel preoperative risk stratification.
    Briganti A; Gallina A; Suardi N; Capitanio U; Tutolo M; Bianchi M; Passoni N; Salonia A; Colombo R; Di Girolamo V; Guazzoni G; Rigatti P; Montorsi F
    J Sex Med; 2010 Jul; 7(7):2521-31. PubMed ID: 20487236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of comorbidity and age in radical prostatectomy].
    Wirth M; Fröhner M
    Urologe A; 2004 Aug; 43(8):935-41. PubMed ID: 15278203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of extracapsular extension is associated with an increased risk of death from prostate cancer after radical prostatectomy for patients with seminal vesicle invasion and negative lymph nodes.
    Mikel Hubanks J; Boorjian SA; Frank I; Gettman MT; Houston Thompson R; Rangel LJ; Bergstralh EJ; Jeffrey Karnes R
    Urol Oncol; 2014 Jan; 32(1):26.e1-7. PubMed ID: 23395235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M; Noldus J; Pichlmeier U; Haese A; Hammerer P; Fernandez S; Conrad S; Henke R; Huland E; Huland H
    Eur Urol; 1999; 36(1):21-30. PubMed ID: 10364651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
    Abdollah F; Sun M; Schmitges J; Thuret R; Bianchi M; Shariat SF; Briganti A; Jeldres C; Perrotte P; Montorsi F; Karakiewicz PI
    J Urol; 2012 Jul; 188(1):73-83. PubMed ID: 22578732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.
    King CR; Freedland SJ; Terris MK; Kane CJ; Amling CL; Aronson WJ; Presti JC
    Urology; 2007 May; 69(5):921-6. PubMed ID: 17482935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.